Those determined to outshine the market strategically focus on the selection of individual stocks. Well-chosen stocks have the potential to substantially boost your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
In the latest session, Cg Oncology Inc. (NASDAQ: CGON) closed at $34.30 down -1.52% from its previous closing price of $34.83. In other words, the price has decreased by -$1.52 from its previous closing price. On the day, 1.99 million shares were traded. CGON stock price reached its highest trading level at $34.94 during the session, while it also had its lowest trading level at $33.4.
Ratios:
For a deeper understanding of Cg Oncology Inc.’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 57.95 and its Current Ratio is at 57.95. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, BofA Securities on June 28, 2024, initiated with a Buy rating and assigned the stock a target price of $65.
On February 20, 2024, Morgan Stanley started tracking the stock assigning a Overweight rating and target price of $55.
On February 20, 2024, Goldman started tracking the stock assigning a Neutral rating and target price of $42.Goldman initiated its Neutral rating on February 20, 2024, with a $42 target price.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Jan 29 ’24 when Decheng Capital Global Life Sc bought 400,000 shares for $19.00 per share. The transaction valued at 7,600,000 led to the insider holds 400,000 shares of the business.
Song Hong Fang bought 263,157 shares of CGON for $4,999,983 on Jan 29 ’24. The Director now owns 613,928 shares after completing the transaction at $19.00 per share. On Jan 29 ’24, another insider, Roche Corleen M., who serves as the CFO & Secretary of the company, bought 2,000 shares for $19.00 each. As a result, the insider paid 38,000 and bolstered with 2,000 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CGON now has a Market Capitalization of 2321077760 and an Enterprise Value of 1719653120. Its current Enterprise Value per Revenue stands at 3190.451 whereas that against EBITDA is -25.222.
Stock Price History:
Over the past 52 weeks, CGON has reached a high of $50.23, while it has fallen to a 52-week low of $25.77. The 50-Day Moving Average of the stock is 4.85%, while the 200-Day Moving Average is calculated to be -6.94%.
Shares Statistics:
For the past three months, CGON has traded an average of 657.05K shares per day and 618660 over the past ten days. A total of 66.64M shares are outstanding, with a floating share count of 40.71M. Insiders hold about 38.90% of the company’s shares, while institutions hold 43.79% stake in the company. Shares short for CGON as of 1719532800 were 5348322 with a Short Ratio of 8.14, compared to 1717113600 on 3634531. Therefore, it implies a Short% of Shares Outstanding of 5348322 and a Short% of Float of 8.1099994.
